Lopinavir/Ritonavir Monotherapy After Virologic Failure of First-Line Antiretroviral Therapy in Resource-Limited Settings

AIDS - United States
doi 10.1097/qad.0b013e328353b066
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

A Qualitative PCR Minipool Strategy to Screen for Virologic Failure and Antiretroviral Drug Resistance in South African Patients on First-Line Antiretroviral Therapy

Journal of Clinical Virology
VirologyInfectious Diseases
2014English

HIV Viral Dynamics of Lopinavir/Ritonavir Monotherapy as Second-Line Treatment: A Prospective, Single-Arm Trial

Journal of the International Association of Providers of AIDS Care
DermatologyInfectious DiseasesImmunology
2019English

An Observational Study in an Urban Ugandan Clinic Comparing Virological Outcomes of Patients Switched From First-Line Antiretroviral Regimens to Second-Line Regimens Containing Ritonavir-Boosted Atazanavir or Ritonavir-Boosted Lopinavir

BMC Infectious Diseases
Infectious Diseases
2019English

Predictive Genotypic Algorithm for Virologic Response to Lopinavir-Ritonavir in Protease Inhibitor-Experienced Patients

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2008English

Random Lopinavir Concentrations Predict Resistance on Lopinavir-Based Antiretroviral Therapy

International Journal of Antimicrobial Agents
MedicineInfectious DiseasesMicrobiologyPharmacology
2016English

Mortality and Long-Term Virologic Outcomes in Children and Infants Treated With Lopinavir/Ritonavir

Pediatric Infectious Disease Journal
Child HealthInfectious DiseasesPediatricsPerinatologyMicrobiology
2013English

PIN65 Cost-Effectiveness of First-Line Antiretroviral Regimens for Human Immunodeficiency Virus (HIV) in Colombia: An Analysis of Lopinavir/Ritonavir (LPV/R) and Darunavir Plus Ritonavir (DRV+RTV) in Treatment-Naïve Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Lack of Effect From a Previous Single Dose of Nevirapine on Virologic and Immunologic Responses After 6 Months of Antiretroviral Regimens Containing Either Efavirenz or Lopinavir-Ritonavir

Pharmacotherapy
Pharmacology
2011English

HIV Drug Resistance Mutations in Patients With HIV and HIV-TB Coinfection After Failure of First-Line Therapy: A Prevalence Study in a Resource-Limited Setting

Journal of the International Association of Providers of AIDS Care
DermatologyInfectious DiseasesImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy